You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 54 No. 6, June 1997 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Comparative Evolution of Alzheimer Disease, Vascular Dementia, and Mixed Dementia

John V. Bowler, MB, MD, MRCP; Michael Eliasziw, PhD; Runa Steenhuis, PhD; David G. Munoz, MD, FRCPC; Rick Fry, MSc; Harold Merskey, DM, FRCPC; Vladimir C. Hachinski, MD, FRCPC, DScMed

Arch Neurol. 1997;54(6):697-703.


Abstract



Objective
To compare the evolution of Alzheimer disease (AD), vascular dementia (VaD), and mixed dementia by cognitive domain.

Setting
The University of Western Ontario Dementia Study, which is a registry of cases of dementia seen for secondary and tertiary assessment in a university memory disorders clinic with extensive follow-up data and histopathological confirmation of clinical diagnoses.

Patients
One hundred twenty-nine patients with definite or probable AD, 12 patients with definite or probable VaD, and 36 patients with definite or probable mixed dementia.

Methods
Patients were grouped as having an early, moderate, or advanced stage of disease according to the extended scale for dementia (ESD). The ESD was subdivided into cognitive domains, and the domain scores were compared for each stage of disease by diagnostic category with the use of a 2-way analysis of variance with repeated measures.

Results
As expected, the scores in all domains decreased significantly with increasing severity. There was a significant difference in the decline in memory among the diagnostic groups (P=.02) that was mostly attributable to the difference between AD and mixed dementia (P=.03), with the difference between AD and VaD only approaching significance (P=.06). There was a similar finding for praxis. The interaction between diagnosis (AD and VaD) and severity was significant only for memory (P=.02), showing a less severe memory deficit at onset but a proportionately more rapid progression in VaD and arithmetic ability (AD and mixed dementia [P=.03]).

Conclusions
Alzheimer disease, VaD, and mixed dementia evolve similarly as assessed using cognitive domains obtained by subdivision of the ESD in a patient population derived from a memory clinic and by analyzing VaD as a single entity. Only memory impairment evolves differently between AD and VaD, with this depending on the severity. Memory is more severely impaired in the early stage of AD; however, with increasing severity of dementia, memory impairment in VaD accelerates and catches up with AD at the level of moderate impairment. The differences between AD and mixed dementia are greater than those between mixed dementia and VaD, suggesting an important role for the ischemic component of mixed dementia. Simple neuropsychological tools (eg, the ESD) may be incapable of distinguishing between AD and VaD, and more focused instruments may be required. Inherent bias in case selection may prevent extrapolation of these results to VaD in general, but the neuropsychological criteria for VaD may need to vary, depending on the severity.



Author Affiliations



From the Departments of Clinical Neurological Sciences (Drs Bowler, Eliasziw, and Hachinski and Mr Fry), Epidemiology and Biostatistics (Drs Eliasziw and Hachinski), Psychiatry (Dr Merskey), and Pathology (Dr Munoz) and the J. P. Robarts Research Institute (Drs Bowler, Eliasziw, Munoz, and Hachinski and Mr Fry), University of Western Ontario, London; and Psychological Services, University Hospital, London, Ontario (Dr Steenhuis). Dr Bowler was a fellow with the Heart and Stroke Foundation of Ontario, London.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease
Bruandet et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:133-139.
ABSTRACT | FULL TEXT  

Chapter 34 Neuropsychological disorders, dementia, and behavioural neurology
Rossor
Brain's Diseases of the Nervous System 2009;12:med-9780198569381-chapter-med-9780198569381-chapter.
ABSTRACT | FULL TEXT  

Galantamine treatment of vascular dementia: A randomized trial
Auchus et al.
Neurology 2007;69:448-458.
ABSTRACT | FULL TEXT  

Challenges in Systematic Reviews That Evaluate Drug Efficacy or Effectiveness
Santaguida et al.
ANN INTERN MED 2005;142:1066-1072.
ABSTRACT | FULL TEXT  

Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia
Graham et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:61-71.
ABSTRACT | FULL TEXT  

Alzheimer Disease as a Vascular Disorder: Nosological Evidence
de la Torre
Stroke 2002;33:1152-1162.
ABSTRACT | FULL TEXT  

Small Concomitant Cerebrovascular Lesions Are Not Important for Cognitive Decline in Severe Alzheimer Disease
Jellinger and Thal
Arch Neurol 2001;58:520-521.
FULL TEXT  

Small Concomitant Vascular Lesions Do Not Influence Rates of Cognitive Decline in Patients With Alzheimer Disease
Lee et al.
Arch Neurol 2000;57:1474-1479.
ABSTRACT | FULL TEXT  

Prevalence and outcomes of vascular cognitive impairment
Rockwood et al.
Neurology 2000;54:447-447.
ABSTRACT | FULL TEXT  

Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease
Bowler et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:18-24.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.